Showing results (31-40 of 154) with videos related to
Sort By:
Pageof 16
Haematologica|July 20, 2019
Validation of Minnesota acute graft-versus-host disease Risk ScoreMargaret L MacMillan, Todd E DeFor, Shernan G Holtan, et al.Archives of Dermatological Research|February 24, 2022
Cross-sectional study of physical activity among long-term melanoma survivors and population controlsAshley E Stenzel, Jonathan Miller, Shernan G Holtan, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2018
Pretransplant Serum Citrulline Predicts Acute Graft-versus-Host DiseaseArmin Rashidi, Ryan Shanley, Shernan G Holtan, et al.Bone Marrow Transplantation|July 30, 2022
Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart reviewShernan G Holtan, Jingbo Yu, Hannah K Choe, et al.Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|October 4, 2022
Adult Hematology/Oncology Patient Perspectives on Telemedicine Highlight Areas of Focus for Future Hybrid Care ModelsAlexander A Boucher, Patricia I Jewett, Shernan G Holtan, et al.Bone Marrow Transplantation|June 23, 2022
Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: A multicenter, retrospective studyShernan G Holtan, Jingbo Yu, Dilan Paranagama, et al.BMJ (Clinical Research Ed.)|October 7, 2021
Advances in acute myeloid leukemiaLaura F Newell, Rachel J CookJournal of Immunology Research|April 14, 2015
Growth modeling of the maternal cytokine milieu throughout normal pregnancy: macrophage-derived chemokine decreases as inflammation/counterregulation increasesShernan G Holtan, Yiyi Chen, Rajani Kaimal, et al.Gut Microbes|August 3, 2022
Fecal β-glucuronidase activity differs between hematopoietic cell and kidney transplantation and a possible mechanism for disparate dose requirementsMohammad Haneef Khan, Guillaume C Onyeaghala, Armin Rashidi, et al.Ejhaem|July 6, 2026
Targeting CD162 for Life-Threatening Cutaneous Chronic Graft-Versus-Host Disease: A Case ReportAlicia Lieberman, Ross McCauley, Maureen Ross, et al.Pageof 16